XTLB
Xtl Biopharmaceuticals
$1.76
−$0.25 (−12.44%)Oct 29, 2026
Key metrics
The numbers that frame XTLB today
- Market cap
- $4.16M
- ROIC
- 1,450.4%
- Div yield
- 0%
- 52wk Low
- $1.65
- 52wk High
- $5.64
Growth
Revenue and earnings trend for XTLB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XTLB
Is Xtl Biopharmaceuticals a good buy?
No. Xtl Biopharmaceuticals has poor quality and poor momentum. Both signals point to a weaker setup. We think Xtl Biopharmaceuticals is selling at a very high price.
What is the market capitalization of XTLB?
Xtl Biopharmaceuticals's market capitalization is $4.16M.
What is the 52-week high for XTLB stock?
The 52-week high for Xtl Biopharmaceuticals is $5.64. The current close of $1.76 is 68.8% below that high.
What is the 52-week low for XTLB stock?
The 52-week low for Xtl Biopharmaceuticals is $1.65. The current close of $1.76 is 6.7% above that low.
Does XTLB stock pay dividends?
Xtl Biopharmaceuticals does not currently show a dividend per share in the company data.